Evidence map›Paper›PMID 33276111›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2021

Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016).

Werner Maokola, Bernard Ngowi, Lovetti Lawson, Masanja Robert, Michael Mahande, Jim Todd, Sia Msuya

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Werner MaokolaMinistry of Health, Community Development, Gender, Elderly and Children, Tanzania; Institute of Public Health, Kilimanjaro Christian Medical University College Moshi Tanzania, Tanzania. Electronic address: drwernerm@yahoo.com.
Bernard NgowiMbeya University College of Health Sciences, Tanzania.
Lovetti LawsonZankli Medical Center, Abuja, Nigeria.
Masanja RobertInstitute of Public Health, Kilimanjaro Christian Medical University College Moshi Tanzania, Tanzania.
Michael MahandeInstitute of Public Health, Kilimanjaro Christian Medical University College Moshi Tanzania, Tanzania.
Jim ToddNational Institute of Medical Research Mwanza, Tanzania; London School of Hygiene and Tropical Medicine, United Kingdom.
Sia MsuyaInstitute of Public Health, Kilimanjaro Christian Medical University College Moshi Tanzania, Tanzania.
Kilimanjaro Christian Medical Centre · TZLondon School of Hygiene & Tropical Medicine · GBMbeya University of Science and Technology · TZMinistry of Health, Community Development, Gender, Elderly and Children · TZZankli Medical Centre · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIsoniazid Preventive Therapy (IPT) is a proven public health tool to reduce Tuberculosis (TB) among people living with HIV. However, its implementation in most countries is suboptimal. This retrospective study was conducted to determine the coverage and factors associated with IPT initiation to inform program scale up and improve quality of service in Tanzania and elsewhere.

methodsRetrospective cohort study design involving HIV clinics in Dar es Salaam, Iringa and Njombe regions from January 2012 to December 2016.

resultsA total of 171,743 PLHIV were in the cohort from 2012 to 2016. Of these, 166,709 were involved in the analysis. Of those analyzed, 23,970 (14.38%) were ever initiated on IPT. Female sex (aOR = 1.72, 95% CI: 1.13, P < 0.001), obesity (aOR = 1.29, 95% CI:1.20-1.39, P < 0.001), WHO clinical stage II (aOR = 1.48, 95% CI: 1.42-1.55, P < 0.001), enrolment in hospitals (aOR = 1.98, 95% CI: 1.89-2.06, P < 0.001), enrolment in Njombe region (aOR = 1.25: 95% CI: 1.18-1.33, P < 0.001) and enrolment in public health facilities (aOR = 1.93: 95% CI: 1.82-2.04, P < 0.001) were associated with increased IPT uptake. Being on ART (aOR = 0.67, 95% CI: 0.65-0.70, P < 0.001) and severe nutritional status (aOR = 0.72, 95% CI: 0.60-0.88, P < 0.001) were associated with decreased IPT initiation.

conclusionsOur study documented low IPT initiation in the study area as well as documented factors which enable IPT initiation and those which impair IPT initiation. Strategies are needed to work on barriers and sustain enabling factors to improve IPT coverage.

Indexed as

AdolescentAdultAntitubercular AgentsChildChild, PreschoolCohort StudiesFemaleHIV InfectionsHumansInfantIsoniazidMaleMiddle AgedRetrospective StudiesTanzaniaTuberculosisAntitubercular AgentsIsoniazidIsoniazid preventive therapyPLHIV and tuberculosisTanzania

Identifiers

PMID33276111
PMCPMC7862080
OpenAlexW3109509617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.